Ledger.Open graph →
SEC Form D · filed October 1, 2020

Carmot Therapeutics Inc

Offering
$46.9M
Sold
$26.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Berkeley, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Aetna Wun K. Trombley · Berkeley, CADirectorStig K. Hansen · Berkeley, CAExec · DirectorPeter K. Svennilson · Berkeley, CADirectorNoah R. Greenhill · San Francisco, CADirectorJessica M. Woolf · San Francisco, CAExec · DirectorIris M. Wu · San Francisco, CADirectorTim K. Kutzky · Berkeley, CADirectorJoseph C. Lawler · CHICAGO, ILDirectorNeil Rose · BAINBRIDGE ISLAND, WADirectorDinkar A. Jetley · NEW YORK, NYExec · DirectorTim K. Kutzky · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗